Fig. 2

The impact of TRMT10C gene expression on the risk, invasion, and prognosis of neuroblastoma. A, TRMT10C gene expression is significantly elevated in neuroblastoma tissues compared with normal adrenal gland tissues. B, TRMT10C gene expression is significantly elevated in the high-risk neuroblastoma group compared with the non-high-risk group. C, TRMT10C gene expression is significantly elevated in stage 4 neuroblastoma patients compared with other clinical stage groups. D-E, Increased expression of the TRMT10C gene is significantly associated with reduced event-free survival (EFS) and overall survival (OS) in neuroblastoma patients